{{Rsnum
|rsid=660541
|Chromosome=11
|Orientation=plus
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene=PGR
|position=101063636
|Gene_s=PGR
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 25.9 | 45.5 | 28.6
| HCB | 62.0 | 33.6 | 4.4
| JPT | 60.2 | 29.2 | 10.6
| YRI | 1.4 | 24.5 | 74.1
| ASW | 10.7 | 26.8 | 62.5
| CHB | 62.0 | 33.6 | 4.4
| CHD | 56.0 | 39.4 | 4.6
| GIH | 40.0 | 44.0 | 16.0
| LWK | 5.6 | 26.9 | 67.6
| MEX | 22.8 | 54.4 | 22.8
| MKK | 9.6 | 34.6 | 55.8
| TSI | 11.8 | 58.8 | 29.4
| HapMapRevision=28
}}Part of a haplotype [[Gs286]], standalone effect for [[endometrial cancer]] is ambiguous.

{{PMID Auto GWAS
|PMID=20547493
|Trait=Endometrial cancer
|Title=Genetic variation in the progesterone receptor gene and risk of endometrial cancer: a haplotype-based approach.
|RiskAllele=G
|Pval=0.31
|OR=1.06
|ORtxt=[0.92-1.22]
|OA=1
}}

{{PMID|15632380}} Clarifying the PROGINS allele association in ovarian and breast cancer risk: a haplotype-based analysis

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}